NCT06239909 Adjustable Artificial Sphincter Victo in the Treatment of Male Incontinence Due to Prostate Surgery
| NCT ID | NCT06239909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Ostrava |
| Condition | Urinary Incontinence |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2018-05-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2018-05-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this prospective academic research study is to evaluate the efficacy and safety of the Victo adjustable artificial sphincter in the treatment of male patients with urinary incontinence due to prostate surgery.
Eligibility Criteria
Inclusion Criteria: * urinary incontinence due to previous prostate surgery * primo-implantation of the artificial urinary sphincter * subject willing and able to give informed consent Exclusion Criteria: \- none
Contact & Investigator
Jan Krhut, prof.,MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital Ostrava
Frequently Asked Questions
Who can join the NCT06239909 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239909 currently recruiting?
Yes, NCT06239909 is actively recruiting participants. Contact the research team at jiri.hyncica@fno.cz for enrollment information.
Where is the NCT06239909 trial being conducted?
This trial is being conducted at Ostrava, Czechia.
Who is sponsoring the NCT06239909 clinical trial?
NCT06239909 is sponsored by University Hospital Ostrava. The principal investigator is Jan Krhut, prof.,MD, PhD at University Hospital Ostrava. The trial plans to enroll 150 participants.